
Key Facts about the Uninsured Population
This issue brief describes trends in health coverage in 2023, examines the characteristics of the uninsured population ages 0-64, and summarizes the access and financial implications of not having coverage.
This issue brief describes trends in health coverage in 2023, examines the characteristics of the uninsured population ages 0-64, and summarizes the access and financial implications of not having coverage.
Acquisition of Mission Cancer + Blood, valued at $280 million, to offer opportunities for oncology specialists to work together to increase access to cancer detection, treatment, and research across Iowa
Free Market Health acquired Beeline Rx, a tech company that streamlines the prior authorization process for specialty drugs. The post Free Market Health Acquires Beeline Rx to Streamline Specialty Prior Auth appeared first on MedCity News.
Ryan Wettstein Nauman was inconsolable one evening last December. After being put down for bed, the 3-year-old from Peoria, Illinois, just kept crying and crying and crying, and nothing would calm her down. Her mother, Maggi Wettstein, remembered fearing it could be a yeast or urinary tract infection, something they had been dealing with during…
Gerri Norington, 78, never wanted to be on her own as she grew old. But her first marriage ended in divorce, and her second husband died more than 30 years ago. When a five-year relationship came to a close in 2006, she found herself alone — a situation that has lasted since. “I miss having…
CEO Paul Mango, and Craig Samitt, M.D., who is heading up the organization’s new value-based care enablement company Longitude PHM, discuss putting an emphasis on specialist care
Nordic Capital acquired a majority stake in health data platform Arcadia. Together, the two aim to accelerate the company’s mission of advancing value-based care through AI and data analytics. Arcadia CEO Michael Meucci views the deal as both a validation of the company’s strategy and part of a broader wave of healthcare investments focused on…
The Federal Trade Commission has sued CVS Caremark, Express Scripts and Optum Rx, alleging that they engage in “anticompetitive and unfair rebating practices” as it relates to insulin. One legal expert believes the FTC might win this legal battle. The post The FTC Is Suing PBMs Over Insulin Prices. Will It Be Successful? appeared first…